McKesson (NYSE:MCK) Stock Rating Upgraded by StockNews.com

McKesson (NYSE:MCK) was upgraded by analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a research report issued on Saturday.

A number of other equities research analysts have also commented on MCK. Morgan Stanley upped their price target on McKesson from $522.00 to $548.00 and gave the company an “overweight” rating in a research report on Monday, April 15th. Leerink Partnrs restated an “outperform” rating on shares of McKesson in a report on Monday, February 26th. Mizuho boosted their price target on shares of McKesson from $450.00 to $505.00 and gave the stock a “neutral” rating in a research report on Friday, February 9th. Argus increased their price objective on shares of McKesson from $510.00 to $570.00 and gave the stock a “buy” rating in a research report on Wednesday, April 10th. Finally, UBS Group boosted their target price on shares of McKesson from $575.00 to $620.00 and gave the company a “buy” rating in a report on Wednesday, March 6th. Two analysts have rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $536.71.

McKesson Trading Down 0.3 %

NYSE:MCK opened at $528.86 on Friday. The stock’s 50-day moving average is $530.38 and its 200-day moving average is $492.60. McKesson has a 1-year low of $352.34 and a 1-year high of $544.81. The stock has a market cap of $69.50 billion, a P/E ratio of 23.96, a price-to-earnings-growth ratio of 1.41 and a beta of 0.45.

McKesson (NYSE:MCK) last posted its earnings results on Wednesday, February 7th. The company reported $7.74 earnings per share for the quarter, topping analysts’ consensus estimates of $7.05 by $0.69. The firm had revenue of $80.90 billion for the quarter, compared to analyst estimates of $77.93 billion. McKesson had a net margin of 0.99% and a negative return on equity of 262.63%. The company’s revenue for the quarter was up 14.8% compared to the same quarter last year. During the same period in the previous year, the firm posted $6.90 EPS. As a group, equities analysts forecast that McKesson will post 27.59 EPS for the current year.

Insider Activity at McKesson

In other McKesson news, EVP Leann B. Smith sold 186 shares of the business’s stock in a transaction that occurred on Tuesday, February 13th. The stock was sold at an average price of $496.00, for a total transaction of $92,256.00. Following the completion of the sale, the executive vice president now directly owns 1,511 shares of the company’s stock, valued at approximately $749,456. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, CEO Brian S. Tyler sold 3,473 shares of the firm’s stock in a transaction dated Friday, March 15th. The shares were sold at an average price of $524.55, for a total transaction of $1,821,762.15. Following the transaction, the chief executive officer now directly owns 43,445 shares of the company’s stock, valued at $22,789,074.75. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Leann B. Smith sold 186 shares of the business’s stock in a transaction that occurred on Tuesday, February 13th. The stock was sold at an average price of $496.00, for a total value of $92,256.00. Following the completion of the transaction, the executive vice president now owns 1,511 shares in the company, valued at approximately $749,456. The disclosure for this sale can be found here. 0.21% of the stock is owned by insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of MCK. OFI Invest Asset Management purchased a new position in shares of McKesson during the 3rd quarter valued at $26,000. Sachetta LLC purchased a new stake in shares of McKesson during the 4th quarter valued at approximately $27,000. Register Financial Advisors LLC bought a new position in McKesson in the 1st quarter worth approximately $29,000. BKM Wealth Management LLC bought a new position in McKesson in the 4th quarter worth approximately $31,000. Finally, Richardson Financial Services Inc. bought a new stake in McKesson during the 4th quarter valued at $31,000. Institutional investors own 85.07% of the company’s stock.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.